Publications | Lund University Publications

1 – 10 of 39

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=department+exact+v1001382&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
3
4
next »

2025
Mark Complement Factor H Is an ICOS Ligand Modulating Tregs in the Glioma Microenvironment
Smolag-Klosowska, Karolina I ^LU ; Olszowka, Jakub ^LU ; Rosberg, Rebecca ^LU ; Johansson, Elinn ^LU ; Marinko, Elisabet ^LU ; Leandersson, Karin ^LU ; O'Connell, David J ; Governa, Valeria ^LU ; Tuysuz, Emre Can ^LU and Belting, Mattias ^LU , et al. (2025) In Cancer immunology research 13(1). p.122-138
- Contribution to journal › Article
Mark Hypogammaglobulinemia at Diagnosis is Associated With Inferior Survival and Higher Risk of Infections in Diffuse Large B Cell Lymphoma
Lindberg, Åsa ^LU ; Johansson, Åsa ^LU ; Kahn, Fredrik ^LU ; Jönsson, Göran ^LU and Jerkeman, Mats ^LU (2025) In Hematological Oncology 43(1).
- Contribution to journal › Article
Mark Lymphomas : ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Eyre, T. A. ; Cwynarski, K. ; d’Amore, F. ; de Leval, L. ; Dreyling, M. ; Eichenauer, D. A. ; Ferreri, A. J.M. ; Giné, E. ; Kersten, M. J. and Ladetto, M. , et al. (2025) In Annals of Oncology 36(11). p.1263-1284
- Contribution to journal › Article
Mark Antisecretory factor as add-on treatment for newly diagnosed glioblastoma, IDH wildtype : study protocol for a randomized double-blind placebo-controlled trial
Ehinger, Erik ^LU ; Darabi, Anna ^LU ; Visse, Edward ^LU ; Edvardsson, Charlotte ^LU ; Tomasevic, Gregor ^LU ; Cederberg, David ^LU ; Kinhult, Sara ^LU ; Rydelius, Anna ^LU ; Nilsson, Christer ^LU and Belting, Mattias ^LU , et al. (2025) In Trials 26(1).
- Contribution to journal › Article
2024
Mark Tattoos as a risk factor for malignant lymphoma: a population-based case–control study
Nielsen, Christel ^LU ; Jerkeman, Mats ^LU and Jöud, Anna ^LU (2024) In EClinicalMedicine 72.
- Contribution to journal › Article
Mark MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma : the Nordic Lymphoma Group MCL7 VALERIA trial
Jerkeman, Mats ^LU ; Kolstad, Arne ; Hutchings, Martin ; Pasanen, Annika ; Meriranta, Leo ; Niemann, Carsten Utoft ; Jørgensen, Rasmus Rask Kragh ; El-Galaly, Tarec Christoffer ; Riise, Jon and Leppä, Sirpa , et al. (2024) In Blood Advances 8(2). p.407-415
- Contribution to journal › Article
Mark Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE) : a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network
Dreyling, Martin ; Doorduijn, Jeanette ; Giné, Eva ; Jerkeman, Mats ^LU ; Walewski, Jan ; Hutchings, Martin ; Mey, Ulrich ; Riise, Jon ; Trneny, Marek and Vergote, Vibeke , et al. (2024) In The Lancet 403(10441). p.2293-2306
- Contribution to journal › Article
Mark Primary central nervous system lymphomas : EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up^☆
Ferreri, A. J.M. ; Illerhaus, G. ; Doorduijn, J. K. ; Auer, D. P. ; Bromberg, J. E.C. ; Calimeri, T. ; Cwynarski, K. ; Fox, C. P. ; Hoang-Xuan, K. and Malaise, D. , et al. (2024) In Annals of Oncology 35(6). p.491-507
- Contribution to journal › Article
Mark Primary central nervous system lymphomas : EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Ferreri, Andreas J.M. ; Illerhaus, Gerald ; Doorduijn, Jeanette K. ; Auer, Dorothee P. ; Bromberg, Jacoline E.C. ; Calimeri, Teresa ; Cwynarski, Kate ; Fox, Christopher P. ; Hoang-Xuan, Khê and Malaise, Denis , et al. (2024) In HemaSphere 8(6).
- Contribution to journal › Article
Mark Outcomes for patients with secondary CNS involvement in relapsed/refractory diffuse large B-cell lymphoma and estimation of eligibility for CAR T-cell therapy
Harrysson, Sara ; Eloranta, Sandra ; Ekberg, Sara ; Enblad, Gunilla ; Andersson, Per Ola ; Sonnevi, Kristina ; Ljungqvist, Maria ; Sander, Birgitta ; Jerkeman, Mats ^LU and Smedby, Karin E. (2024) In Leukemia and Lymphoma 65(4). p.534-537
- Contribution to journal › Letter

« previous
1
2
3
4
next »

your query:: Remove department: Oncology corporate